{"result": "(\"entity\"<|>HUP LA FE<|>ORGANIZATION<|>HUP La Fe is a hospital that provides guidelines for the administration of medications via enteral feeding tubes.)\n##\n(\"entity\"<|>E. LÓPEZ BRIZ<|>PERSON<|>E. López Briz is one of the authors contributing to the recommendations for medication administration via enteral feeding tubes.)\n##\n(\"entity\"<|>A. VÁZQUEZ POLO<|>PERSON<|>A. Vázquez Polo is one of the authors contributing to the recommendations for medication administration via enteral feeding tubes.)\n##\n(\"entity\"<|>P. MARRERO ÁLVAREZ<|>PERSON<|>P. Marrero Álvarez is one of the authors contributing to the recommendations for medication administration via enteral feeding tubes.)\n##\n(\"entity\"<|>K. GARCÍA<|>PERSON<|>K. García is one of the authors contributing to the algorithm for managing diarrhea in enteral nutrition.)\n##\n(\"entity\"<|>M. ARGENTE<|>PERSON<|>M. Argente is one of the authors contributing to the algorithm for managing diarrhea in enteral nutrition.)\n##\n(\"entity\"<|>M. PÉREZ<|>PERSON<|>M. Pérez is one of the authors contributing to the algorithm for managing diarrhea in enteral nutrition.)\n##\n(\"entity\"<|>DIARREA<|>EVENT<|>Diarrhea is a condition that may occur in patients receiving enteral nutrition, requiring specific management protocols.)\n##\n(\"relationship\"<|>E. LÓPEZ BRIZ<|>HUP LA FE<|>E. López Briz is an author of the recommendations provided by HUP La Fe for medication administration via enteral feeding tubes.<|>7)\n##\n(\"relationship\"<|>A. VÁZQUEZ POLO<|>HUP LA FE<|>A. Vázquez Polo is an author of the recommendations provided by HUP La Fe for medication administration via enteral feeding tubes.<|>7)\n##\n(\"relationship\"<|>P. MARRERO ÁLVAREZ<|>HUP LA FE<|>P. Marrero Álvarez is an author of the recommendations provided by HUP La Fe for medication administration via enteral feeding tubes.<|>7)\n##\n(\"relationship\"<|>K. GARCÍA<|>DIARREA<|>K. García is an author of the algorithm for managing diarrhea in enteral nutrition.<|>7)\n##\n(\"relationship\"<|>M. ARGENTE<|>DIARREA<|>M. Argente is an author of the algorithm for managing diarrhea in enteral nutrition.<|>7)\n##\n(\"relationship\"<|>M. PÉREZ<|>DIARREA<|>M. Pérez is an author of the algorithm for managing diarrhea in enteral nutrition.<|>7)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ación |\n---\n# Anexo 1: RECOMENDACIONES GENERALES PARA LA ADMINISTRACIÓN DE MEDICAMENTOS POR SONDA ENTERAL\n\nE. López Briz, A. Vázquez Polo, P. Marrero Álvarez\n\nLa nutrición por sonda (nasogástrica, nasoentérica o por gastrostomía) constituye una práctica frecuente en los hospitales, en ocasiones como único aporte alimenticio o bien como paso previo a la nutrición parenteral o para finalizarla de manera gradual. Es frecuente que la colocación de la sonda dificulte al personal de enfermería la administración de los fármacos orales, lo que origina numerosas consultas al Servicio de Farmacia y, probablemente, no pocos errores.\n\nNo en todos los medicamentos puede disponerse de la vía parenteral y en ocasiones ésta no se aconseja, por lo que es necesario disponer de repertorios hospitalarios adaptados a los medicamentos usados en el hospital que informen acerca de cómo administrar éstos de manera correcta cuando el paciente lleva sonda enteral (SE), así como de unos principios generales de manejo de la sonda.\n\nEn la siguiente tabla se recogen los principales aspectos a tener en cuenta en la administración de medicamentos por SE.\n\n- Comprobar la localización del extremo distal de la sonda (gástrica o duodenal).\n\n- Consultar la manera de administrar los medicamentos pautados. El programa Prisma de prescripción asistida del HUP La Fe dispone de una base de datos de administración de medicamentos por SE. En ocasiones será necesario valorar la elaboración de formulaciones extemporáneas o sustituir el principio activo por otro.\n\n- Seguir las recomendaciones en cuanto a modo de administración respecto a la NE para evitar interacciones fármaco-nutrición. Con algunos medicamentos es necesario interrumpir la dieta antes y después de la administración del medicamento.\n\n- Lavar la sonda con 15-30 ml de agua antes y después de la administración de cada fármaco, para evitar incompatibilidades, prevenir la obstrucción de la sonda y asegurar que todo el fármaco es administrado.\n\n- En general, la manera de proceder depende de la forma farmacéutica:\n  - Los comprimidos de liberación inmediata y los que tienen cubierta pelicular generalmente se pueden triturar hasta polvo fino.\n  - Los comprimidos de liberación retardada no deben triturarse, ya que la trituración destruye las características de liberación.\n---\n- Los comprimidos con cubierta entérica no deben triturarse; la pérdida de la cubierta puede provocar la inactivación del principio activo o favorecer la irritación de la mucosa gástrica.\n\n- Los comprimidos efervescentes deben disolverse en agua y esperar a que finalice la efervescencia antes de administrar.\n\n- Los comprimidos sublinguales no es recomendable administrarlos por SE.\n\n- Las cápsulas de gelatina dura (contenido en polvo) pueden abrirse para disolver su contenido en agua y administrar.\n\n- Las cápsulas de gelatina dura conteniendo microgránulos pueden abrirse, pero los microgránulos no deben triturarse. La posibilidad de la administración depende en gran medida del diámetro de los microgránulos y del de la sonda.\n\n- En las cápsulas de gelatina blanda (contenido líquido) no se recomienda la manipulación. Consultar antes de la administración.\n\n• Cuando hay que administrar más de un fármaco al mismo paciente, administrar cada medicación de forma separada. En el caso de formas farmacéuticas líquidas se recomienda administrar primero las formulaciones de menor viscosidad y a continuación las de mayor viscosidad.\n\n• No añadir NUNCA medicamentos a la bolsa de nutrición enteral.\n\n• Lavar la sonda cada 4 h con 15-30 ml agua.\n---\n# Anexo 2: ALGORITMO DE MANEJO DE DIARREA EN NUTRICIÓN ENTERAL\n\nK. García, M. Argente, M. Pérez\n\n```mermaid\ngraph TD\n    A[¿Hay distensión abdominal?] --> B[Suspender dieta y valoración clínica]\n    C[¿Se administra mediante bomba de perfusión?] --> |SI| D[Disminuir a la mitad el ritmo de infusión]\n    C --> |NO| E[Usar bomba de perfusión]\n    F[¿Sospecha de infección por C. difficile?] --> G[Solicitar toxina de C. difficile y coprocultivo]\n    H[¿Sospecha de impactación fecal?] --> I[Extraer]\n    J[¿Está con tratamiento antibiótico?] --> K[Valorar suspender tratamiento]\n    J --> L[Cambiar tipo de dieta]\n    M[¿Está en tratamiento con laxantes o procinéticos?] --> N[Administrar dieta con hidrolizado de goma guar]\n    M --> O[Valorar el uso de fármacos antidiarreicos]\n```\n\nModificado de\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}